To accelerate breakthroughs, the Damon Runyon Foundation provides today's best young scientists with funds to pursue innovative cancer research.
- Today’s Promising Areas of Cancer Research
- What is Cancer?
- A Broken Pipeline?
A Generation of Science at Risk
- ARISE Report
Early Career Scientists and High-Risk, High Reward Research - American Academy of Arts and Sciences
- Why We’re Losing the War on Cancer (And How To Win It)
Clifton Leaf - Fortune Magazine
September 5, 2005
Peter P. Lee, MD (Damon Runyon Scholar '01-'03) has developed a new way to assess the risk of breast cancer recurrence. Dr. Lee looked at what types of immune cells were present in the lymph nodes of 77 breast cancer patients and found that the pattern of immune cells could predict the chances that the cancer would recur.